J. Li, K. Echevarria, and K. Traugott, Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol.4, issue.Suppl, pp.346-60, 2017.
DOI : 10.4103/0976-500X.120957

S. Rao, N. Rhodes, B. Lee, M. Scheetz, A. Hanson et al., Treatment Outcomes with Cefazolin versus Oxacillin for Deep-Seated Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections, Antimicrobial Agents and Chemotherapy, vol.59, issue.9, pp.5232-5240, 2015.
DOI : 10.1128/AAC.04677-14

I. Youngster, E. Shenoy, D. Hooper, and S. Nelson, Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-­?susceptible Staphylococcus aureus infections in the outpatient setting. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.369-75, 2014.

L. Flynt, R. Kenney, M. Zervos, and S. Davis, The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections, Infectious Diseases and Therapy, vol.53, issue.8, pp.225-256
DOI : 10.1128/AAC.00317-09

S. Pollett, S. Baxi, G. Rutherford, S. Doernberg, P. Bacchetti et al., Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center, Antimicrobial Agents and Chemotherapy, vol.60, issue.8, pp.4684-4693, 2016.
DOI : 10.1128/AAC.00243-16

S. Lee, K. Song, S. Jung, W. Park, S. Lee et al., Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea, Clinical Microbiology and Infection, 2017.
DOI : 10.1016/j.cmi.2017.07.001

P. Loubet, C. Burdet, W. Vindrios, N. Grall, M. Wolff et al., Cefazolin versus anti-­?staphylococcal penicillins for treatment of methicillin-­?susceptible Staphylococcus aureus bacteraemia: a narrative review Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis Available from: https://www.pasteur.fr/fr/centre-­?medical/fiches-­?maladies/staphylocoque 11 The changing epidemiology of Staphylococcus aureus bloodstream infection : a multinational population-­?based surveillance study, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.1019, issue.5, pp.465-71, 2013.

F. Gudiol, J. Aguado, B. Almirante, E. Bouza, E. Cercenado et al., Diagnosis and treatment of bacteraemia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), Enferm Infecc Microbiol Clin, vol.33, issue.9, pp.625-626, 2015.

M. Bassetti, M. Peghin, E. Trecarichi, A. Carnelutti, E. Righi et al., Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality, PLOS ONE, vol.3, issue.2, p.170236, 2017.
DOI : 10.1371/journal.pone.0170236.s002

P. Braquet, A. F. Cornu, C. Goehringer, F. Piroth, L. Chirouze et al., Factors associated with 12??week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study, Clinical Microbiology and Infection, vol.22, issue.11, pp.948-949, 2016.
DOI : 10.1016/j.cmi.2016.07.034

URL : https://hal.archives-ouvertes.fr/hal-01417891

L. Moing, V. , A. F. Doco-­?lecompte, T. Delahaye, F. Piroth et al., Staphylococcus aureus Bloodstream Infection and Endocarditis - A Prospective Cohort Study, PLOS ONE, vol.30, issue.5, p.127385, 2015.
DOI : 10.1371/journal.pone.0127385.t005

URL : https://hal.archives-ouvertes.fr/hal-01299980

Y. Rhee, A. Aroutcheva, B. Hota, R. Weinstein, and K. Popovich, CONCLUSIONS, Infection Control & Hospital Epidemiology, vol.52, issue.12, pp.1417-1439, 2015.
DOI : 10.1086/528716

A. Société-de-pathologies-infectieuse-de-langue-française-del-rio, C. Cervera, A. Moreno, P. Moreillon, and J. Miró, Recommandations de pratique clinique Infections ostéo-­?articulaires sur matériel (prothèse, implant, ostéosynthèse) Available from: http://www.infectiologie.com/fr/recommandations.html 18 Patients at risk of complications of Staphylococcus aureus bloodstream infection, pp.246-53, 2009.

S. Tubiana, X. Duval, A. F. Selton-­?suty, C. Tattevin, P. Delahaye et al., The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia, Journal of Infection, vol.72, issue.5, 2016.
DOI : 10.1016/j.jinf.2016.02.003

URL : https://hal.archives-ouvertes.fr/hal-01309268

L. López-­?cortés, D. Toro, M. Gálvez-­?acebal, J. Bereciartua-­?bastarrica, E. Fariñas et al., Impact of an Evidence-Based Bundle Intervention in the Quality-of-Care Management and Outcome of Staphylococcus aureus Bacteremia, Clinical Infectious Diseases, vol.57, issue.9, pp.1225-1258, 2013.
DOI : 10.1093/cid/cit499

A. Tice, S. Rehm, J. Dalovisio, J. Bradley, L. Martinelli et al., Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.1651-72, 2004.

F. Candel, A. Julián-­?jiménez, and J. Castillo, Current status in outpatient parenteral antimicrobial therapy: a practical view, pp.55-68, 2016.

A. Lacroix, M. Revest, S. Patrat-­?delon, F. Lemaître, E. Donal et al., Outpatient parenteral antimicrobial therapy for infective endocarditis: A cost-effective strategy, M??decine et Maladies Infectieuses, vol.44, issue.7, pp.327-357
DOI : 10.1016/j.medmal.2014.05.001

URL : https://hal.archives-ouvertes.fr/hal-01146253

C. Cervera, A. Del-río, L. García, M. Sala, M. Almela et al., Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study, Enfermedades Infecciosas y Microbiolog??a Cl??nica, vol.29, issue.8
DOI : 10.1016/j.eimc.2011.05.007

M. Yan, M. Elligsen, A. Simor, N. Daneman, A. Luce et al., Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study Outpatient parenteral antimicrobial therapy for the treatment of methicillin-­?susceptible Staphylococcus aureus : a comparison of cefazolin and ceftriaxone, Can J Infect Dis Med Microbiol J Can Mal Infect Microbiol Medicale. Infection, vol.201641, issue.4, pp.769-74, 2013.

M. Paul, N. Zemer-­?wassercug, O. Talker, Y. Lishtzinsky, L. B. Samra et al., Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?, Clinical Microbiology and Infection, vol.17, issue.10, pp.1581-1587, 2011.
DOI : 10.1111/j.1469-0691.2010.03425.x

S. Lee, P. Choe, K. Song, S. Park, H. Kim et al., Is Cefazolin Inferior to Nafcillin for Treatment of Methicillin-­?Susceptible Staphylococcus aureus Bacteraemia? Antimicrob Agents Chemother, pp.5122-5128, 2011.

J. Li, K. Echevarria, D. Hughes, J. Cadena, J. Bowling et al., Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.58, issue.9, pp.5117-5141, 2014.
DOI : 10.1128/AAC.02800-14

A. Bai, A. Showler, L. Burry, M. Steinberg, D. Ricciuto et al., Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study, Journal of Antimicrobial Chemotherapy, vol.70, issue.5, pp.1539-1585
DOI : 10.1093/jac/dku560

E. Nannini, M. Stryjewski, K. Singh, A. Bourgogne, T. Rude et al., Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure, Antimicrobial Agents and Chemotherapy, vol.53, issue.8, 2009.
DOI : 10.1128/AAC.00317-09

D. Zygmunt, C. Stratton, and D. Kernodle, Characterization of four beta-lactamases produced by Staphylococcus aureus., Antimicrobial Agents and Chemotherapy, vol.36, issue.2, pp.440-445, 1992.
DOI : 10.1128/AAC.36.2.440

S. Rincón, J. Reyes, L. Carvajal, N. Rojas, F. Cortés et al., Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals, Journal of Antimicrobial Chemotherapy, vol.68, issue.12, pp.2773-2781, 2013.
DOI : 10.1093/jac/dkt254

S. Lee, K. Kwon, H. Kim, H. Chang, J. Lee et al., Bacteremia, Microbial Drug Resistance, vol.20, issue.6, pp.568-74, 2014.
DOI : 10.1089/mdr.2013.0229

K. Song, S. Jung, S. Lee, S. Park, S. Kiem et al., Characteristics of cefazolin inoculum effect-­?positive methicillin-­?susceptible Staphylococcus aureus infection in a multicentre bacteraemia cohort, Eur J Clin Microbiol Infect Dis, 2017.

C. Et-troubles-de-la-coagulation, Available from, 2017.

H. Knothe, G. Dette, and P. Shah, Einflu?? parenteraler Cephalosporine auf die gastrointestinale Mikroflora: Untersuchungen bei gesunden Freiwilligen und hospitalisierten Patienten, Infection, vol.14, issue.Suppl. B, pp.129-162, 1985.
DOI : 10.1007/BF01644233

Y. Takesue, T. Yokoyama, S. Akagi, H. Ohge, Y. Imamura et al., Changes in the Intestinal Flora After the Administration of Prophylactic Antibiotics to Patients Undergoing a Gastrectomy, Surgery Today, vol.32, issue.7, pp.581-587, 2002.
DOI : 10.1007/s005950200105

M. Bassetti, E. Righi, A. Astilean, S. Corcione, A. Petrolo et al., Antimicrobial prophylaxis in minor and major surgery, Minerva Anestesiol. 2015, vol.81, issue.1, pp.76-91

W. Liu, M. Ni, Y. Zhang, R. Groen, A. Maraolo et al., Antibiotic prophylaxis in craniotomy: a review Efficacy of ultra-­? short single agent regimen antibiotic chemo-­?prophylaxis in reducing the risk of meningitis in patients undergoing endoscopic endonasal transsphenoidal surgery, Neurosurg Rev. 2014 Clin Neurol Neurosurg, vol.37, issue.3, pp.407-421, 2015.

J. Gérard, C. Zerr, P. Lebreton, P. Renouf, Y. Lecharpentier et al., Antibioprophylaxie en chirurgie cardiaque : c??fazoline ?? 12 hversus c??fazoline ?? 36 h, Annales Fran??aises d'Anesth??sie et de R??animation, vol.6, issue.2, pp.83-90, 1987.
DOI : 10.1016/S0750-7658(87)80108-9

F. Wellens, M. Pirlet, R. Larbuisson, D. Meireleire, F. et al., Prophylaxis in cardiac surgery. A controlled randomized comparison between cefazolin and cefuroxime, Eur J Cardio-­? Thorac Surg Off J Eur Assoc Cardio-­?Thorac Surg, vol.9, issue.6, pp.325-334, 1995.

C. Lanckohr, D. Horn, S. Voeller, G. Hempel, M. Fobker et al., Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery, The Journal of Thoracic and Cardiovascular Surgery, vol.152, issue.2, pp.603-613, 2016.
DOI : 10.1016/j.jtcvs.2016.04.024

R. Aznar, M. Mateu, J. Miró, J. Gatell, J. Gimferrer et al., Antibiotic prophylaxis in non-cardiac thoracic surgery: Cefazolin versus placebo, European Journal of Cardio-Thoracic Surgery, vol.5, issue.10, pp.515-523, 1991.
DOI : 10.1016/1010-7940(91)90103-Q

F. Recker, S. Geroulanos, and M. Turina, [Perioperative antibiotic prophylaxis in heart and vascular surgery. A prospective randomized comparative study with cefazolin and ceftriaxone

M. Marroni, P. Cao, M. Fiorio, M. Maghini, M. Lenti et al., Prospective, Randomized, Double-Blind Trial Comparing Teicoplanin and Cefazolin as Antibiotic Prophylaxis in Prosthetic Vascular Surgery, European Journal of Clinical Microbiology and Infections Diseases, vol.18, issue.3, pp.175-183, 1999.
DOI : 10.1007/s100960050253

W. Pories, A. Van-rij, B. Burlingham, R. Fulghum, and D. Meelheim, Prophylactic cefazolin in gastric bypass surgery, Surgery, vol.90, issue.2, pp.426-458, 1981.

Y. Ise, K. Hagiwara, S. Saitoh, K. Honjo, S. Soh et al., Comparison of the effects of prophylactic antibiotic therapy and cost-­?effectiveness between cefazolin (CEZ) and

/. Sulbactam and . Ampicillin, SBT/ABPC) in gastric cancer surgery employing clinical pathway]. Yakugaku Zasshi, pp.815-839, 2004.

H. Xu, J. Wang, M. Tsai, K. Wu, S. Chiou et al., The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions, Surgical Endoscopy, vol.21, issue.9, pp.2911-2919, 2011.
DOI : 10.3346/jkms.2006.21.5.883

A. Prophylaxis and I. Bariatric, SURGERY: a continuous infusion of cefazolin versus ampicillin/sulbactam and ertapenem, Arq Gastroenterol. 2015, vol.52, issue.2, pp.83-90

J. Jenícek, T. Fait, A. Jedlicková, and J. Zivný, Antibiotic prophylaxis of infectious complications in cesarean section-­?-­?prospective study], Ceska Gynekol, vol.64, issue.5, pp.313-319, 1999.

J. Popovi?, Z. Gruji?, and A. Sabo, Influence of pregnancy on ceftriaxone, cefazolin and gentamicin pharmacokinetics in caesarean vs. non-pregnant sectioned women, Journal of Clinical Pharmacy and Therapeutics, vol.51, issue.14, 2007.
DOI : 10.1128/AAC.33.6.797

Z. Gruji?, J. Popovi?, M. Bogavac, and I. Gruji?, Preoperative administration of cephalosporins for elective caesarean delivery. Srp Arh Celok Lek, pp.9-10600, 2010.

A. Shakya and J. Sharma, Comparison of single versus multiple doses of antibiotic prophylaxis in reducing post-elective Caesarean section infectious morbidity, Kathmandu University Medical Journal, vol.8, issue.2, 2010.
DOI : 10.3126/kumj.v8i2.3554

J. Simões, M. Discacciati, G. Poletti, E. Brolazo, G. Crema et al., Tinidazole versus cefazolin in antibiotic prophylaxis of vaginal and abdominal hysterectomy]. Rev Bras Ginecol E Obstet Rev Fed Bras Soc Ginecol E Obstet, pp.544-553, 2008.

N. Phoolcharoen, S. Nilgate, O. Rattanapuntamanee, S. Limpongsanurak, and S. Chaithongwongwatthana, A randomized controlled trial comparing ceftriaxone with cefazolin for antibiotic prophylaxis in abdominal hysterectomy, International Journal of Gynecology & Obstetrics, vol.87, issue.(1), pp.11-14, 2012.
DOI : 10.1016/S0025-7125(02)00145-1

H. Autorité-de-santé-­?-prothèse-de-hanche-ou-de-genou, diagnostic et prise en charge de l'infection dans le mois suivant l'implantation [Internet] Available from: https://www.has-­?sante.fr/portail/jcms/c_1228574/fr/prothese-­?de-­?hanche-­?ou-­?de-­?genou-­?diagnostic-­? et-­?prise-­?en-­?charge-­?de-­?l-­?infection-­?dans-­?le-­?mois-­?suivant-­?l-­?implantation 65. Société de Pathologie infectieuse de Langue Française. Recommandations pour la pratique clinique. Spondylodiscites infectieuses primitives, et secondaires à un geste intra-­?discal, sans mise en pace de matériel, 2007.

J. Li, K. Echevarria, D. Hughes, J. Cadena, J. Bowling et al., Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.58, issue.9, pp.5117-5141, 2014.
DOI : 10.1128/AAC.02800-14

D. Murdoch, G. Corey, B. Hoen, J. Miró, V. Fowler et al., Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century, Archives of Internal Medicine, vol.169, issue.5, pp.463-73, 2009.
DOI : 10.1001/archinternmed.2008.603

URL : https://hal.archives-ouvertes.fr/hal-00464774